强化护士家访项目对医疗补助合格人群不良出生结局的影响:一项随机临床试验
这项随机临床试验纳入5670名医疗补助合格、孕周小于28周的初产妇,于2016年4月1日至2020年3月17日入组,随访至2021年2月。参与者按2:1随机分配至护士家庭伙伴关系项目(n=3806)或对照组(n=1864),干预组从产前开始定期家访并持续至产后2年。主要终点之一为早产、低出生体重、小于胎龄儿或围产期死亡的复合不良出生结局,可分析人群为4966人(干预组3319人,对照组1647人),干预组发生率为26.9%,对照组为26.1%,调整后组间差异0.5%(95%CI -2.1%至3.1%)。在总体样本或任一预设亚组中,干预组任何母婴健康主要或次要结局均未显著改善。
要点
- 在4966名可分析参与者中,复合不良出生结局发生率干预组26.9% vs 对照组26.1%,调整后组间差异0.5%(95%CI -2.1%至3.1%),未达统计学显著。
- 干预组在总体样本及两个预设亚组中,母婴健康主要和次要结局均无显著改善。
- 该试验纳入5670名医疗补助合格、孕周小于28周的初产妇,随机分组2:1,干预为护士家庭伙伴关系项目,从产前持续至产后2年。
- 研究基于南卡罗来纳州人群,随访至2021年2月,其他主要结局(短于21个月的生育间隔、儿童24个月内重大伤害或虐待/忽视关切)测量尚未完成。
适用人群与场景
- 医疗补助合格、初产妇、孕周小于28周的孕妇,于2016年4月1日至2020年3月17日入组,随访至2021年2月。
- 研究基于南卡罗来纳州,参与者中位年龄21岁,种族构成包括非西班牙裔亚裔、原住民或夏威夷及太平洋岛民1.2%,西班牙裔5.7%,非西班牙裔黑人55.2%,非西班牙裔白人34.8%,报告多于1个种族(非西班牙裔)3.0%。
处置流程与药物剂量
- 护士家庭伙伴关系项目:定期家访从产前开始并持续至产后2年,护士提供教育、评估和目标设定,涉及产前健康、儿童健康与发育及母亲生活历程。
- 对照组接受常规护理服务及社区资源列表。
- 参与者和工作人员均未对干预分组设盲。
研究设计与关键结果
- 研究类型:随机临床试验,纳入5670名医疗补助合格、孕周小于28周的初产妇,随机2:1分配至护士家庭伙伴关系项目(n=3806)或对照组(n=1864),可分析主要母婴健康结局者4966人(干预组3319人,对照组1647人)。
- 主要终点(复合不良出生结局:早产、低出生体重、小于胎龄儿或围产期死亡)发生率:干预组26.9% vs 对照组26.1%,调整后组间差异0.5%(95%CI -2.1%至3.1%)。
- 在总体样本或两个预设亚组中,干预组任何母婴健康主要或次要结局均未显著改善。
- 次要结局包括复合结局各要素以及出生体重、孕周、大于胎龄儿、极早产、极低出生体重、新生儿重症监护病房过夜入住、严重孕产妇发病率及剖宫产。
- 其他主要结局(短于21个月的生育间隔、儿童24个月内重大伤害或虐待/忽视关切)测量尚未完成。
证据类型、等级与局限
- 证据类型:随机临床试验;试验注册号ClinicalTrials.gov NCT03360539。
- 局限:参与者和工作人员均未对干预分组设盲;其他主要结局(短于21个月的生育间隔、儿童24个月内重大伤害或虐待/忽视关切)测量尚未完成,项目总体有效性评估不完整。
对床旁实践的改变
- 作者认为,在该基于南卡罗来纳州的医疗补助合格孕妇试验中,分配至强化护士家访项目并未显著降低复合不良出生结局的发生率。
- 作者指出,对该项目总体有效性的评估尚不完整,有待完成对幼儿期和生育间隔结局的评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Improving birth outcomes for low-income mothers is a public health priority. Intensive nurse home visiting has been proposed as an intervention to improve these outcomes.
OBJECTIVE: To determine the effect of an intensive nurse home visiting program on a composite outcome of preterm birth, low birth weight, small for gestational age, or perinatal mortality.
DESIGN, SETTING, AND PARTICIPANTS: This was a randomized clinical trial that included 5670 Medicaid-eligible, nulliparous pregnant individuals at less than 28 weeks' gestation, enrolled between April 1, 2016, and March 17, 2020, with follow-up through February 2021.
INTERVENTIONS: Participants were randomized 2:1 to Nurse Family Partnership program (n = 3806) or control (n = 1864). The program is an established model of nurse home visiting; regular visits begin prenatally and continue through 2 postnatal years. Nurses provide education, assessments, and goal-setting related to prenatal health, child health and development, and maternal life course. The control group received usual care services and a list of community resources. Neither staff nor participants were blinded to intervention group.
MAIN OUTCOMES AND MEASURES: There were 3 primary outcomes. This article reports on a composite of adverse birth outcomes: preterm birth, low birth weight, small for gestational age, or perinatal mortality based on vital records, Medicaid claims, and hospital discharge records through February 2021. The other primary outcomes of interbirth intervals of less than 21 months and major injury or concern for abuse or neglect in the child's first 24 months have not yet completed measurement. There were 54 secondary outcomes; those related to maternal and newborn health that have completed measurement included all elements of the composite plus birth weight, gestational length, large for gestational age, extremely preterm, very low birth weight, overnight neonatal intensive care unit admission, severe maternal morbidity, and cesarean delivery.
RESULTS: Among 5670 participants enrolled, 4966 (3319 intervention; 1647 control) were analyzed for the primary maternal and neonatal health outcome (median age, 21 years [1.2% non-Hispanic Asian, Indigenous, or Native Hawaiian and Pacific Islander; 5.7% Hispanic; 55.2% non-Hispanic Black; 34.8% non-Hispanic White; and 3.0% more than 1 race reported [non-Hispanic]). The incidence of the composite adverse birth outcome was 26.9% in the intervention group and 26.1% in the control group (adjusted between-group difference, 0.5% [95% CI, -2.1% to 3.1%]). Outcomes for the intervention group were not significantly better for any of the maternal and newborn health primary or secondary outcomes in the overall sample or in either of the prespecified subgroups.
CONCLUSIONS AND RELEVANCE: In this South Carolina-based trial of Medicaid-eligible pregnant individuals, assignment to participate in an intensive nurse home visiting program did not significantly reduce the incidence of a composite of adverse birth outcomes. Evaluation of the overall effectiveness of this program is incomplete, pending assessment of early childhood and birth spacing outcomes.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03360539.
参考来源
- McConnell MA, Rokicki S, Ayers S, et al. Effect of an Intensive Nurse Home Visiting Program on Adverse Birth Outcomes in a Medicaid-Eligible Population: A Randomized Clinical Trial. JAMA. 2022. PMID: 35788794. doi:10.1001/jama.2022.9703
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。